Press Releases

Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework

May 14, 2015

Silver Spring, Md., April 20, 2015—The American Association of Homeopathic Pharmacists (AAHP) today told the U.S. Food and Drug Administration that the agency’s regulatory policy for homeopathic medicines has worked effectively for the last 25 years to protect the public health and provide consumer access to safe homeopathic medicines. AAHP, the industry’s trade association, was…

AAHP Addresses OTC Homeopathic Drug Products for Asthma

March 30, 2015

The American Association of Homeopathic Pharmacists (AAHP), representing the principal manufacturers and distributors of homeopathic medicines in the United States, said today it fully supports the Food and Drug Administration’s position that consumers should seek the advice of their health care provider if they suspect they or their children are experiencing symptoms of asthma, which…

Sept ’14 Member Meeting Successes

October 13, 2014

The AAHP’s Semi-Annual Member Meeting in Baltimore was an unparalleled success with two new highlights capping the event. After an opening welcome by AAHP President Mark Land, the meeting began with an informative roundtable discussion by Al Lorman, Pete Evich and Jay Borneman. Each provided a quick perspective on current challenges facing the industry. Among…

Homeopathy officially recognized in Belgium

June 4, 2014

The practice of homeopathy received a legal recognition in Belgium on last month, but at the same time stricter regulations have been imposed on the sector.The federal government gave the green light in July last year, but the Royal Decree was only published in the Staatsblad, the official news letter issued by the Belgian government,…

AAHP Response to AP Article on Zicam

June 19, 2009

Homeopathic Pharmacists Association Highlights the Extraordinary Safety Record of Homeopathic Medicines June 19, 2009—The American Association of Homeopathic Pharmacists (AAHP) acknowledges the U.S. Food and Drug Administration’s (FDA) action to protect the public by sending a Warning Letter to Matrixx Innovations, Inc. in connection with that company’s sale of Zicam intranasal zinc medications. According to…

AAHP Statement Regarding FDA Action Against Zicam

June 19, 2009

AAHP Statement Regarding FDA Action Against Zicam Intranasal Zinc Products June 19, 2009–The American Association of Homeopathic Pharmacists (AAHP) acknowledges the U.S. Food and Drug Administration’s (FDA) action to protect the public by sending a Warning Letter to Matrixx Innovations, Inc. in connection with that company’s sale of Zicam intranasal zinc medications. According to FDA,…

Leave a Comment

You must be logged in to post a comment.